FGF23 and left ventricular hypertrophy: Diminished α-Klotho—linked to both declining eGFR and protein-bound uremic toxins—raises fibroblast growth factor 23 (FGF23) levels, worsening vascular dysfunction and left ventricular hypertrophy [93,94,95].